Ameriprise
ROIV icon

Ameriprise’s Roivant Sciences ROIV Stock Holding History

Ameriprise’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.8M Buy
701,644
+263,079
+60% +$7.77M 0.01% 1377
2026
Q1 		$12.1M Sell
438,565
-206,883
-32% -$5.31M ﹤0.01% 1783
2025
Q4 		$14M Buy
645,448
+197,087
+44% +$3.89M ﹤0.01% 1666
2025
Q3 		$6.78M Sell
448,361
-14,808
-3% -$183K ﹤0.01% 2194
2025
Q2 		$5.22M Buy
463,169
+17,233
+4% +$187K ﹤0.01% 2331
2025
Q1 		$4.5M Sell
445,936
-8,146
-2% -$88.1K ﹤0.01% 2391
2024
Q4 		$5.37M Sell
454,082
-5,293
-1% -$62.6K ﹤0.01% 2308
2024
Q3 		$5.3M Buy
459,375
+76,078
+20% +$866K ﹤0.01% 2334
2024
Q2 		$4.05M Buy
383,297
+5,886
+2% +$64.5K ﹤0.01% 2461
2024
Q1 		$3.98M Buy
+377,411
New +$4.07M ﹤0.01% 2506

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Ameriprise's ROIV Position: Q2 2026 in Review

Ameriprise increased its Roivant Sciences (ROIV) stake by 60% in Q2 2026, buying an estimated $7.77M and bringing the position to 701,644 shares worth $24.8M. The position accounts for 0.01% of the portfolio, ranked #1377.

Ameriprise first reported a position in ROIV in Q1 2024 and has held it in 10 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Ameriprise held 701,644 shares of Roivant Sciences worth $24.8M as of Q2 2026.
  • Ameriprise bought 263,079 Roivant Sciences shares in Q2 2026, an estimated $7.77M.
  • Roivant Sciences made up 0.01% of Ameriprise's portfolio in Q2 2026, its #1377 holding.
  • Ameriprise first reported a position in Roivant Sciences in Q1 2024 and has held it in 10 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.